Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
2.260
0.00 (0.00%)
At close: Dec 5, 2025
Nuo Therapeutics Employees
Nuo Therapeutics had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$290,172
Profits / Employee
-$270,045
Market Cap
108.66M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Nuo Therapeutics News
- 7 months ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 8 months ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 2 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 2 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire